Hiroto Egawa

Tokyo Women's University

Japan

November 18 (Fri)
10:30 - 12:00
Concurrent Symposium 2 (Liver)
How to Improve Long-term Outcome after LT
English Room 5F-1
Chair(s) Arvinder Soin (Medanta Institute of Liver Transplantation and Regenerative Medicine, India)
Yang Won Nah (University of Ulsan, Korea)
10:30 - 10:45
Optimal Immunosuppression-Early vs Late
Arvinder Soin (Medanta Institute of Liver Transplantation and Regenerative Medicine, India)
10:45 - 11:00
Surveillance and Prevention for De-Novo Malignancies except PTLD
Taizo Hibi (Kummamoto University, Japan)
11:00 - 11:15
How to Diagnose & Manage PTLD
Dok Hyun Yoon (Asan Medical Center, University of Ulsan, Korea)
11:15 - 11:30
Long-term Outcome of Periopertive Renal Dysfunction in LT
Prashant Bhangui (Medanta Institute of Liver Transplantation and Regenerative Medicine, India)
11:30 - 11:45
Recurrence of Original Disease after LT - Focus What?
Hiroto Egawa (Tokyo Women's University, Japan)
11:45 - 12:00
Discussion

November 19 (Sat)
08:40 - 10:00
KJTF Symposium 1 (Liver)
Immune Tolerance
English Room 5F-1
Chair(s) Hiroto Egawa (Tokyo Women's University, Japan)
Myoung Soo Kim (Yonsei University, Korea)
08:40 - 09:00
Complete withdrawal of immunosuppression in pediatric patient
Seak Hee Oh (Asan Medical Center, University of Ulsan, Korea)
09:00 - 09:20
Standing at a crossroad: Biomarkers for Rejection or Torelance
Jong Young Choi (The Catholic University of Korea, Korea)
09:20 - 09:40
Phase 1/2 multicenter clinical trial of tolerance induction in living donor liver transplantation via induced T cells with suppressing functions
Koichiro Uchida (Juntendo University, Japan)
09:40 - 10:00
Operational tolerance induced by a donor antigen specific immunomodulatory cell therapy in living donor liver transplantation
Masaaki Watanabe (Hokkaido University, Japan)